Entyvio

List of products in the National Drug Code with proprietary name entyvio. This medication is used to treat certain bowel disorders (ulcerative colitis, Crohn's disease). In these conditions, the body's defense system (immune system) attacks healthy tissues in the gut, causing symptoms such as abdominal pain, blood in the stool, and diarrhea. Vedolizumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking the actions of a certain natural substance (integrin) in the body. This helps to decrease swelling (inflammation) in the gut, which lessens symptoms and may slow or stop damage from these bowel disorders.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
64764-107Entyvio VedolizumabInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug
64764-300Entyvio VedolizumabInjection, Powder, Lyophilized, For SolutionIntravenousTakeda Pharmaceuticals America, Inc.Human Prescription Drug